FDA Approves Jardiance to Improve Glycemic Control in Type 2 Diabetes

Drug Industry Daily
A A
The FDA approved Boehringer Ingelheim and Eli Lilly’s diabetes drug Jardiance, reversing its rejection this spring based on quality concerns at one of BI’s plants where the drug is made.

To View This Article:

Login

Subscribe To Drug Industry Daily